These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35638299)

  • 41. Yellow fever: a reemerging threat.
    Gardner CL; Ryman KD
    Clin Lab Med; 2010 Mar; 30(1):237-60. PubMed ID: 20513550
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rifapentine is an entry and replication inhibitor against yellow fever virus both in vitro and in vivo.
    Qian X; Wu B; Tang H; Luo Z; Xu Z; Ouyang S; Li X; Xie J; Yi Z; Leng Q; Liu Y; Qi Z; Zhao P
    Emerg Microbes Infect; 2022 Dec; 11(1):873-884. PubMed ID: 35249454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
    Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
    J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus.
    Beauclair G; Streicher F; Chazal M; Bruni D; Lesage S; Gracias S; Bourgeau S; Sinigaglia L; Fujita T; Meurs EF; Tangy F; Jouvenet N
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
    Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
    Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiviral Activity of Benzavir-2 against Emerging Flaviviruses.
    Gwon YD; Strand M; Lindqvist R; Nilsson E; Saleeb M; Elofsson M; Överby AK; Evander M
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32235763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease.
    Silva NIO; Sacchetto L; de Rezende IM; Trindade GS; LaBeaud AD; de Thoisy B; Drumond BP
    Virol J; 2020 Jan; 17(1):9. PubMed ID: 31973727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A real-time reverse transcription loop-mediated isothermal amplification assay for the rapid detection of yellow fever virus.
    Kwallah Ao; Inoue S; Muigai AW; Kubo T; Sang R; Morita K; Mwau M
    J Virol Methods; 2013 Oct; 193(1):23-7. PubMed ID: 23692685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses.
    Dubankova A; Boura E
    Antiviral Res; 2019 Sep; 169():104536. PubMed ID: 31202975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.
    James EA; LaFond RE; Gates TJ; Mai DT; Malhotra U; Kwok WW
    J Virol; 2013 Dec; 87(23):12794-804. PubMed ID: 24049183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The seasonal influence of climate and environment on yellow fever transmission across Africa.
    Hamlet A; Jean K; Perea W; Yactayo S; Biey J; Van Kerkhove M; Ferguson N; Garske T
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006284. PubMed ID: 29543798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Experimental Adaptation of the Yellow Fever Virus to the Mosquito Aedes albopictus and Potential risk of urban epidemics in Brazil, South America.
    Amraoui F; Pain A; Piorkowski G; Vazeille M; Couto-Lima D; de Lamballerie X; Lourenço-de-Oliveira R; Failloux AB
    Sci Rep; 2018 Sep; 8(1):14337. PubMed ID: 30254315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plant-Produced Subunit Vaccine Candidates against Yellow Fever Induce Virus Neutralizing Antibodies and Confer Protection against Viral Challenge in Animal Models.
    Tottey S; Shoji Y; Jones RM; Chichester JA; Green BJ; Musiychuk K; Si H; Manceva SD; Rhee A; Shamloul M; Norikane J; Guimarães RC; Caride E; Silva ANMR; Simões M; Neves PCC; Marchevsky R; Freire MS; Streatfield SJ; Yusibov V
    Am J Trop Med Hyg; 2018 Feb; 98(2):420-431. PubMed ID: 29231157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells.
    Cong Y; McArthur MA; Cohen M; Jahrling PB; Janosko KB; Josleyn N; Kang K; Zhang T; Holbrook MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004709. PubMed ID: 27191161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination and antiviral treatment of neglected diseases caused by flaviviral infections.
    Schleich K; Nürnberger C; Sobanski A; Efferth T
    Curr Med Chem; 2011; 18(4):604-14. PubMed ID: 21143108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Yellow fever: a disease that has yet to be conquered.
    Barrett AD; Higgs S
    Annu Rev Entomol; 2007; 52():209-29. PubMed ID: 16913829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bis(Benzofuran-1,3-
    Gupta NK; Jayakumar S; Huang WC; Leyssen P; Neyts J; Bachurin SO; Hwu JR; Tsay SC
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Persistence of Neutralizing Antibody Responses Among Yellow Fever Virus 17D Vaccinees Living in a Nonendemic Setting.
    Kareko BW; Booty BL; Nix CD; Lyski ZL; Slifka MK; Amanna IJ; Messer WB
    J Infect Dis; 2020 Jun; 221(12):2018-2025. PubMed ID: 31545367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.